Published in Thromb Haemost on September 01, 2002
Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One (2012) 3.68
Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection. J Virol (2008) 1.14
HIV-Associated Venous Thromboembolism. Mediterr J Hematol Infect Dis (2011) 1.11
Cardiovascular disease in HIV infection. Curr Opin HIV AIDS (2011) 1.08
The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms. Curr Opin HIV AIDS (2009) 0.96
Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study. AIDS Res Ther (2015) 0.81
The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active. J Mol Biol (2007) 0.80
Comment: raised soluble P selectin and the risk of thrombosis in HIV-1 infection. Thromb Haemost (2002) 0.76
Packed cell volume Platelet count, PT, PTTK and Fibrinogen concentration of HIV positive patients on antiretroviral drugs. Pak J Med Sci (2016) 0.75
Diagnostic dilemma of coagulation problems in an HIV-positive patient with end-stage liver disease undergoing liver transplantation. World J Transplant (2015) 0.75
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med (2003) 6.57
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol (2005) 3.51
Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest (2007) 2.36
Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation (2010) 2.25
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med (2008) 2.01
A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am (2002) 1.83
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project. Blood (2013) 1.69
Exposure, health and ecological effects review of engineered nanoscale cerium and cerium oxide associated with its use as a fuel additive. Crit Rev Toxicol (2011) 1.52
Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation (2003) 1.51
Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation. Urology (2013) 1.41
Predicting emergency department admissions. Emerg Med J (2011) 1.34
Will working memory training generalize to improve off-task behavior in children with attention-deficit/hyperactivity disorder? Neurotherapeutics (2012) 1.29
Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol (2003) 1.25
D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation (2003) 1.22
Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One (2012) 1.21
Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanisms. PLoS One (2011) 1.21
Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol (2006) 1.20
The osteo-odonto-keratoprosthesis (OOKP). Semin Ophthalmol (2005) 1.18
D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc (2005) 1.16
Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation (2008) 1.12
Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thromb Haemost (2002) 1.12
Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol (2007) 1.09
Controlled differentiation of human bone marrow stromal cells using magnetic nanoparticle technology. Tissue Eng Part A (2010) 1.08
Management of Clostridium difficile in NHS trusts. BMJ (2006) 1.07
Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Thromb Haemost (2002) 1.03
Exploring the positional attachment of glycopeptide/beta-lactam heterodimers. J Antibiot (Tokyo) (2008) 1.01
Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony-stimulating factor. Br J Haematol (2007) 1.00
Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate. Mol Cell Biol (2002) 1.00
β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis. J Clin Invest (2014) 1.00
Towards a synthetic osteo-odonto-keratoprosthesis. Acta Biomater (2008) 0.99
The impact of the congestion charging scheme on air quality in London. Part 1. Emissions modeling and analysis of air pollution measurements. Res Rep Health Eff Inst (2011) 0.96
Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer. J Gerontol A Biol Sci Med Sci (2006) 0.95
Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer. Theranostics (2011) 0.94
Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease. J Am Geriatr Soc (2004) 0.94
Circulating blood markers and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2008) 0.94
Particulate matter oxidative potential from waste transfer station activity. Environ Health Perspect (2010) 0.94
Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease. Vasc Med (2004) 0.89
Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies. Thromb Res (2011) 0.88
Unique biochemical and behavioral alterations in Drosophila shibire(ts1) mutants imply a conformational state affecting dynamin subcellular distribution and synaptic vesicle cycling. J Neurobiol (2002) 0.87
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography. BJU Int (2007) 0.86
13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Atherosclerosis (2012) 0.86
Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk). Blood (2003) 0.86
Cerebral monitoring in patients undergoing carotid endarterectomy using a triple assessment technique. Interact Cardiovasc Thorac Surg (2010) 0.85
Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study. Contemp Clin Trials (2013) 0.85
The impact of the congestion charging scheme on air quality in London. Part 2. Analysis of the oxidative potential of particulate matter. Res Rep Health Eff Inst (2011) 0.85
VTE prophylaxis in aesthetic surgery patients. Aesthet Surg J (2009) 0.85
Quantification of nanoparticle interactions in pure solvents and a concentrated PDMS solution as a function of solvent quality. Langmuir (2013) 0.83
Engaging physicians to adopt healthcare information technology. J Healthc Manag (2009) 0.83
Postpartum hemorrhage management in 2012: predicting the future. Int J Gynaecol Obstet (2012) 0.83
Delivery of S1P receptor-targeted drugs via biodegradable polymer scaffolds enhances bone regeneration in a critical size cranial defect. J Biomed Mater Res A (2013) 0.83
Substance misuse, anxiety and depression and urgency of presentation to a public emergency department in Australia. Emerg Med Australas (2005) 0.82
Gender differences in the relationships between alcohol, tobacco and mental health in patients attending an emergency department. Alcohol Alcohol (2004) 0.82
Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide. J Med Chem (2008) 0.82
Efficacy of combining GMX1777 with radiation therapy for human head and neck carcinoma. Clin Cancer Res (2010) 0.82
Biomolecular predictors of urothelial cancer behavior and treatment outcomes. Curr Urol Rep (2012) 0.82
Packed red blood cell transfusion causes greater hemoglobin rise at a lower starting hemoglobin in patients with subarachnoid hemorrhage. Neurocrit Care (2008) 0.81
A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium. Hum Mol Genet (2011) 0.81
Straightforward, one-step synthesis of alkanethiol-capped silver nanoparticles from an aggregative model of growth. Langmuir (2013) 0.81
Anti-amyloid-β-mediated positron emission tomography imaging in Alzheimer's disease mouse brains. PLoS One (2012) 0.81
Comparison of effects of statin use on mortality in patients with peripheral arterial disease with versus without elevated C-reactive protein and d-dimer levels. Am J Cardiol (2010) 0.80
Long-term change in alcohol-consumption status and variations in fibrinogen levels: the coronary artery risk development in young adults (CARDIA) study. BMJ Open (2013) 0.80
Importance of cutaneous cooling during photothermal epilation: theoretical and practical considerations. Lasers Surg Med (2002) 0.80
Hemoglobin C and hemoglobin O-Arab variants can be diagnosed using the Bio-Rad Variant II high-performance liquid chromatography system without further confirmatory tests. Arch Pathol Lab Med (2004) 0.79
Hematologic findings in children with rotavirus-positive and -negative diarrhea. Pediatr Hematol Oncol (2003) 0.79
Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)). Thromb Haemost (2009) 0.79
Evaluation of an authority innovation-decision: brief alcohol intervention for pregnant women receiving women, infants, and children services at two Illinois health departments. Subst Use Misuse (2014) 0.79
Acquired hemophilia: diagnosis and management. Curr Hematol Rep (2002) 0.79
Vitamin D status, functional decline, and mortality in peripheral artery disease. Vasc Med (2014) 0.79
Multiple myeloma presenting as mesenteric venous thrombosis and intestinal infarction. Dig Dis Sci (2005) 0.79
Design and synthesis of 4,5-disubstituted-thiophene-2-amidines as potent urokinase inhibitors. Bioorg Med Chem Lett (2002) 0.79
An electrochemiluminescence-based competitive displacement immunoassay for the type-2 brevetoxins in oyster extracts. J AOAC Int (2007) 0.78
Emergency care workload units: a novel tool to compare emergency department activity. Emerg Med Australas (2010) 0.78
The Implementation and Evaluation of the Patient Admission Prediction Tool: Assessing Its Impact on Decision-Making Strategies and Patient Flow Outcomes in 2 Australian Hospitals. Qual Manag Health Care (2015) 0.78
Nanoparticle stability in semidilute and concentrated polymer solutions. Langmuir (2008) 0.77
Surface area controlled heterogeneous nucleation. J Chem Phys (2012) 0.77
Fusion of FNA-cytology and gene-expression data using Dempster-Shafer Theory of evidence to predict breast cancer tumors. Bioinformation (2006) 0.77
Implementing an emergency department patient admission predictive tool: insights from practice. J Health Organ Manag (2010) 0.77
ASH evidence-based guidelines: statins in the prevention of venous thromboembolism. Hematology Am Soc Hematol Educ Program (2009) 0.76
Analysis of neuron-specific enolase and S100B as biomarkers of cognitive decline following surgery in older people. Dement Geriatr Cogn Disord (2012) 0.76
Implementation and outcomes of a severe sepsis protocol in an Australian tertiary hospital. Crit Care Resusc (2008) 0.75
Fabrication of hydroxyapatite sponges by dextran sulphate/amino acid templating. Biomaterials (2005) 0.75
Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells. Urol Oncol (2011) 0.75
Screen for dominant behavioral mutations caused by genomic insertion of P-element transposons in Drosophila: an examination of the integration of viral vector sequences. J Neurogenet (2007) 0.75
Flu vaccine--a must for all midwives. Midwives (2011) 0.75
Using bispectral index and cerebral oximetry to guide hemodynamic therapy in high-risk surgical patients. Perioper Med (Lond) (2013) 0.75
Exhaustive study of the novel hyper alkalophil, thermostable, and chelator resistant metalloprotease. Appl Biochem Biotechnol (2015) 0.75
Folding 'health' back into healthcare. Health Estate (2015) 0.75
Rubella screening cessation. Midwives (2016) 0.75
PREVENTING PERTUSSIS. Midwives (2015) 0.75
Autoworkers write to the President. New Solut (2009) 0.75
Point prevalence of patients fulfilling MET criteria in ten MET equipped hospitals. The methodology of the RESCUE study. Resuscitation (2011) 0.75
Overview of cancer and thrombosis. Cancer Treat Res (2009) 0.75
The impact of a temporary medical ward closure on emergency department and hospital service delivery outcomes. Qual Manag Health Care (2011) 0.75
Fighting flu. Midwives (2015) 0.75
Patients undergoing surgical resection of primary brain tumors should receive pharmacologic venous thromboprophylaxis. Med Clin North Am (2003) 0.75